Single cell analysis of haematopoietic stem cells
Methods in Molecular Biology
MetadataShow full item record
Sturgess, K., Calero Nieto, F., Gottgens, B., & Wilson, N. Single cell analysis of haematopoietic stem cells. Methods in Molecular Biology https://doi.org/10.17863/CAM.58114
The study of haematopoiesis has been revolutionized in recent years by the application of single cell RNA sequencing technologies. The technique coupled with rapidly developing bioinformatic analysis has provided great insight into the cell type compositions of many populations previously defined by their cell surface phenotype. Moreover, transcriptomic information enables the identification of individual molecules and pathways which define novel cell populations and their transitions including cell lineage decisions. Combining single cell transcriptional profiling with molecular perturbations allows functional analysis of individual factors in gene regulatory networks and better understanding of the earliest stages of malignant transformation. In this chapter we describe a comprehensive protocol for scRNA-Seq analysis of the mouse bone marrow, using both plate-based (low throughput) and droplet-based (high throughput) methods. The protocol includes instructions for sample preparation, an antibody panel for flow cytometric purification of haematopoietic progenitors with index sorting for plate-based analysis or in bulk for droplet-based methods. The plate-based protocol described in this chapter is a combination of the Smart-Seq2 and mcSCRB-Seq protocols, optimized in our laboratory. It utilizes off-the-shelf reagents for cDNA preparation, is amenable to automation using a liquid handler, and takes 4 days from preparation of the cells for sorting to producing a sequencing-ready library. The droplet-based method (using for instance the 10x Genomics platform) relies on the manufacturer’s user guide and commercial reagents, and takes 3 days from isolation of the cells to the production of a library ready for sequencing.
This is a methods chapter which didn't include a funding statement. We can request the publisher if this can be added during proof stage.
Wellcome Trust (206328/Z/17/Z)
Embargo Lift Date
This record's DOI: https://doi.org/10.17863/CAM.58114
This record's URL: https://www.repository.cam.ac.uk/handle/1810/311024
All rights reserved